Literature DB >> 23582164

Early surgical excision of giant congenital hemangiomas of the scalp in newborns: clinical indications and reconstructive aspects.

Luigino Santecchia1, Maria Francesca Bianciardi Valassina, Federica Maggiulli, Giorgio Spuntarelli, Rita De Vito, Mario Zama.   

Abstract

BACKGROUND: Infantile hemangioma is the most common vascular tumor in newborns, with an incidence from 12 to 23% among preterm infants with low weight at birth and a female to male ratio of 3:1. The head and neck is the most frequently affected area (60%), and the scalp is a typical site for such large lesions.
OBJECTIVE: We describe some clinical and medical aspects in comparison with the surgical approach to giant infantile hemangioma of the scalp.
METHODS: The indications to treatment are discussed. An outcome basis evaluation, by reviewing some clinical cases, is provided to help readers better understand when and how to undergo surgery safely.
CONCLUSION: Early excision of huge infantile hemangioma of the scalp is the treatment of choice if feasible within 5 months of age.

Entities:  

Mesh:

Year:  2013        PMID: 23582164     DOI: 10.2310/7750.2012.11113

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  3 in total

1.  Preoperative trans-arterial embolization of a giant scalp congenital hemangioma associated with cardiac failure in a premature newborn.

Authors:  Abdulelah A Alluhaybi; Sarah Bin Abdulqader; Khalid Altuhayni; Abdulellah AlTurkstani; Aseel Kabbani; Maqsood Ahmad
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

2.  Surgical management of large scalp infantile hemangiomas.

Authors:  Imad S Khan; Erin N Kiehna; Komal F Satti; Moneeb Ehtesham; Mahan Ghiassi; Robert J Singer
Journal:  Surg Neurol Int       Date:  2014-03-27

3.  Early Surgical Management of Large Scalp Infantile Hemangioma Using the TopClosure® Tension-Relief System.

Authors:  Zhanyong Zhu; Xilin Yang; Yueqiang Zhao; Huajun Fan; Mosheng Yu; Moris Topaz
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.